Breast Cancer Screening Options for Women With ATM, CHEK2, PALB2

moderators
moderators Posts: 8,651
edited May 2022 in Genetic Testing

Study Suggests Breast Cancer Screening Options for Women With ATM, CHEK2, and PALB2 Mutations
Mar 22, 2022

Women with ATM, CHEK2, or PALB2 mutations may benefit from starting annual breast cancer screening with MRI between the ages and 30 to 35 and an annual MRI and mammogram starting at age 40. Read more...